ATLASInovio Pharmaceuticals (INO) earnings date: Nov 9, 2026
Inovio Pharmaceuticals (INO) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$0.20.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INO
| Last price | $2.06 (+242.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Inovio Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Inovio Pharmaceuticals reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Inovio Pharmaceuticals. You can switch it off at any time.
Alert me before INO reportsFree to start. Creating an account takes under a minute.
Notify me when Inovio Pharmaceuticals reports
Track INO free Add Inovio Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
INO earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.20 |
| Last report | Aug 12, 2026 · In line |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +13.7% |
| Average move around a report | ±7.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Inovio Pharmaceuticals earnings history: last 5 reports
Inovio Pharmaceuticals last reported on Aug 12, 2026: EPS of -$0.24 against an estimate of -$0.24 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.24 | -$0.24 | 0.0% | In line | +16.9% |
| May 13, 2026 | -$0.33 | -$0.31 | +6.1% | Beat | -3.6% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | +7.7% |
| Mar 12, 2026 | -$0.34 | -$0.28 | +17.7% | Beat | -1.8% |
| Mar 2, 2026 | -$0.54 | -$0.70 | -29.6% | Miss | -7.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INO
See the fair value, the probability range and the earnings history of Inovio Pharmaceuticals on its ATLAS page.
Inovio Pharmaceuticals (INO) stock analysisPlans from €3.99 a month.
Inovio Pharmaceuticals earnings: frequently asked questions
When does Inovio Pharmaceuticals (INO) report earnings?
Inovio Pharmaceuticals is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for INO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.20 per share (USD). Estimates can change before the report.
How often does INO beat earnings estimates?
Of its last 5 reports with a recorded result, Inovio Pharmaceuticals beat the EPS estimate 3 times; the average surprise was +13.7%. Past results do not predict the next one.
How much does INO move around earnings?
Over its last 5 reports the stock moved an average of 7.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Inovio Pharmaceuticals beat earnings estimates last quarter?
Inovio Pharmaceuticals last reported on Aug 12, 2026: EPS of -$0.24 against an estimate of -$0.24 (0.0% surprise), in line with the estimate.
How much does INO usually move in a day?
On a normal trading day the ATLAS model puts INO’s one-day range at about ±8.2%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer